Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamiparib PK study with Rifampin and Itraconazole
NCT03994211Phase 1Completed
- Sponsor
- BeiGene
- Start
- May 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 1, open-label trial of pamiparib in solid tumor (3 arms), sponsored by BeiGene. Primary endpoints: Maximum Observed Concentration, Area Under the Curve from Time Zero to Last Quantifiable Concentration and 6 more. Started May 2019; status: completed.
02
Drugs
pamiparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03994211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994211.